96723 ⎘
Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links; Tetrapeptides with the first amino acid being neutral and aliphatic the side chain containing 2 to 4 carbon atoms, e.g. Val, Ile, Leu
PEPTIDE HAVING ANTI-INFLAMMATORY ACTIVITY AND USE THEREOF
#2Compound - diagnostic marker for kidney cancer, method for detecting enzymatic activity, method for diagnosis of kidney cancer, kit comprising the compound, uses of the compound and method for the treatment of kidney cancer
#3METHODS FOR REDUCING CD36 EXPRESSION
#4AQUEOUS PEPTIDE PROGRAMMING OF THE VINYLIDENE FLUORIDE FERROELECTRIC PHASE
#5COMPOUND - DIAGNOSTIC MARKER FOR INTESTINAL CANCER, METHOD FOR DETECTING ENZYMATIC ACTIVITY, METHOD FOR DIAGNOSIS OF INTESTINAL CANCER, KIT COMPRISING THE COMPOUND, USES OF THE COMPOUND AND METHOD FOR THE TREATMENT OF INTESTINAL CANCER
#6DRUG CONJUGATES FOR BONE MARROW PROTECTION
#7METHODS FOR THE TREATMENT OF MITOCHONDRIAL DISEASE
#8POLYPEPTIDE COMPOUND AND USE THEREOF IN TREATMENT OF ENTERITIS
#9Protease inhibitors
#10NOVEL AURISTATIN ANALOGS AND IMMUNOCONJUGATES THEREOF
#11ANTIVIRAL LARAZOTIDE DERIVATIVES
#12SELECTIVE SMALL MOLECULE AGONISTS AND PARTIAL AGONISTS OF TRK RECEPTORS
#13POLYPEPTIDE TARGETING INTEGRIN ALPHA 6 AND USE THEREOF
#14PEPTIDES FOR USE IN SKIN AND HAIR PIGMENTATION
#15CYTOTOXIC COMPOUNDS AND CONJUGATES THEREOF
#16CASPASE-3-TRIGGERED MOLECULAR SELF-ASSEMBLING PET PROBES AND USES THEREOF
#17COSMETIC TETRAPEPTIDE, COMPOSITION AND USE
#18TETRAPEPTIDE AND COMPOSITIONS COMPRISING TETRAPEPTIDES
#19RESPIRATORY TREATMENTS
#20TETRAPEPTIDE AND COMPOSITIONS COMPRISING TETRAPEPTIDES
#21TETRAPEPTIDES, COMPOSITIONS COMPRISING THEM, AND THEIR COSMETIC USE
#22TETRAPEPTIDES, COMPOSITIONS COMPRISING THEM, AND THEIR COSMETIC USE
#23POLYPEPTIDE FOR REPAIRING MUCOSAL DAMAGE OR SKIN WOUND AND USE THEREOF
#243D NEURONAL TISSUE GRAFTS USING ULTRASHORT SELF-ASSEMBLING PEPTIDE SCAFOLDS
#25METHODS FOR REDUCING CD36 EXPRESSION
#26HEPATITIS C VIRUS NS3/4A PROTEASE INHIBITORS
#27ULTRASOUND-ASSISTED SIMULATED DIGESTION METHOD OF CASEIN ACTIVE PEPTIDE AND APPLICATION THERE OF IN HEALTH FOODS
#28Peptides and compositions for inhibiting hair growth
#29DOLASTATIN 10 ANALOG
#30COMPOSITIONS CONTAINING, METHODS INVOLVING, AND USES OF NON-NATURAL AMINO ACID LINKED DOLASTATIN DERIVATIVES
#31LABYRINTHIN-BASED PEPTIDES FOR CANCER IMMUNOTHERAPIES AND USES THEREOF
#32BIOMATERIAL COMPOSITE, PEPTIDE-BASED ADHESIVES AND METHODS OF USE THEREOF
#33Fill-finish process for peptide solutions
#34THIOSTREPTON ANALOGS AND METHODS OF MAKING AND USING SAME
#35FILL-FINISH PROCESS FOR PEPTIDE SOLUTIONS
#36INHIBITORS OF GROWTH FACTOR ACTIVATION ENZYMES
#37COMPOUND, SYNTHESIS INTERMEDIATE, USE, PHARMACEUTICAL COMPOSITION AND NEUROMODULATORY THERAPEUTIC METHOD
#38SITE-SPECIFIC CHEMOENZYMATIC PROTEIN MODIFICATIONS
#39THIAZOLYL PEPTIDES FOR THE TREATMENT NONTUBERCULOUS MYCOBACTERIAL INFECTIONS
#40PEPTIDE COMPOUND WITH REPETITIVE SEQUENCES
#41A METHOD FOR INCREASING ROMIDEPSIN PRODUCTION FROM FERMENTATION BROTH
#42GEMINOID LIPOPEPTIDE COMPOUNDS AND THEIR USES
#43PEPTIDE INHIBITORS OF TIGHT JUNCTION PERMEABILITY
#44Peptides for treatment of medical disorders
#45Peptides for activation of cell signaling in osteoprogenitor cells
#46METHOD FOR PRODUCING PEPTIDE COMPOUND, PROTECTIVE GROUP-FORMING REAGENT, AND CONDENSED POLYCYCLIC AROMATIC HYDROCARBON COMPOUND
#47Novel chemiluminescent substrates for Factor Xa
#48Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
#49LLP2A-BISPHOSPHONATE CONJUGATES FOR OSTEOPOROSIS TREATMENT
#50Toll-like receptor 4 (TLR4) inhibitors and use thereof
#51Cyclic compound/peptide comprising an A-beta13-16 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-beta13-16 peptide
#52Cyclic compound/peptide comprising an A-beta15-18 peptide and a linker that is covalently coupled to the n-terminus residue and the c-terminus residue of the A-BETA15-18 peptide
#53Methods for reducing CD36 expression
#54Compositions comprising cyclic peptides derived from an A-beta peptide
#55FILL-FINISH PROCESS FOR PEPTIDE SOLUTIONS
#56CHIRAL PEPTIDES
#57LLP2A-BISPHOSPHONATE CONJUGATES FOR OSTEOPOROSIS TREATMENT
#58Immune-stimulating soluble doxorubicin-conjugated complex
#59Peptide inhibitors of tight junction permeability
#60Ultrasound-assisted simulated digestion method of milk protein active peptide and application thereof in health foods
#61Hepatitis C virus NS3/4A protease inhibitors
#62Caspase-3-triggered molecular self-assembling PET probes and uses thereof
#63AZAINDOLINE COMPOUNDS AS GRANZYME B INHIBITORS
#64MALT1 inhibitors and uses thereof
#65Methods and compositions for detecting or measuring caspases or apoptosis
#66Site-specific chemoenzymatic protein modifications
#67GEMINOID LIPOPEPTIDE COMPOUNDS AND THEIR USES
#68METHODS FOR REDUCING CD36 EXPRESSION
#69Synthetic peptide amides
#70Chiral peptides
#71Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#72PHENYL PROPANAMIDE DERIVATIVE, AND MANUFACTURING METHOD AND PHARMACEUTICAL APPLICATION THEREOF
#73Peptides having tetrahedral mimicking groups as inhibitors of rhomboid proteases
#74Legumain Activated Doxorubicin Derivative as well as Preparation Method and Application Thereof
#75Neuropeptide S receptor (NPSR) agonists
#76PAR2 mimetic peptides and uses thereof
#77Connective tissue stimulating peptides
#78PRE-TREATMENT AGENT AND PRE-TREATMENT METHOD FOR ANTITHROMBIN III TO BE SUBJECTED TO LIMULUS TEST
#79Cleavable peptides and insecticidal and nematicidal proteins comprising same
#80METHODS AND MATERIALS FOR GENERATING T CELLS
#81Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#82Anti-amyloid beta antibodies binding to a cyclic amyloid beta peptide
#83Process for the preparation of (1S, 4S, 7Z, 10S, 16E, 21R)-7-ethyldene-4,21-bis(1-methyl-ethyl)-2-oxa-12,13-dithia-5,8,20,23-tetraazabicyclo[8.7.6]tricos-16-ene-3, 6, 9, 19, 22-pentone
#84Biologically Cleavable Tetrapeptide Linking Agents
#85MALT1 inhibitors and uses thereof
#86ARTIFICIAL PEPTIDES AND USE THEREOF FOR GLYCOGEN STORAGE DISORDERS
#87Antibacterial and fungicidal peptide in which lysine and tryptophan residues are repeated, and use thereof
#88Inhibition of gliadin peptides
#89Dipeptidyl peptidase-IV (DPPIV), inhibitory peptide compound, composition containing the same, and production method for the same
#90PERIPHERAL KAPPA OPIOID RECEPTOR AGONISTS FOR UREMIC PRURITUS IN DIALYSIS PATIENTS
#91Inhibitors of growth factor activation enzymes
#92CYCLIC PEPTIDE COMPOUND, AND PREPARATION AND USE THEREOF
#93Pro-Amb reverse turn restricted bioactive peptide analogues
#94Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
#95Process for purification of Carfilzomib
#96SFRP5-derived peptide fragment and cosmetic composition for skin whitening containing same
#97METHODS FOR REDUCING CD36 EXPRESSION
#98Smart Pro-Drugs of Serine Protease Inhibitors
#99Azaindoline compounds as granzyme B inhibitors
#100LLP2A-bisphosphonate conjugates for osteoporosis treatment
#101Peptides for promoting angiogenesis and use thereof
#102Legumain activated doxorubicin derivative as well as preparation method and application thereof
#103AURISTATIN TYRAMINE PHOSPHATE SALTS AND AURISTATIN AMINOQUINOLINE DERIVATIVES AND PRODRUGS THEREOF
#104INHIBITION OF GLIADIN PEPTIDES
#105Macrocyclic broad spectrum antibiotics
#106Sfrp5-derived peptide fragment and cosmetic composition for skin whitening containing same
#107Process for isolation of romidepsin from fermentation broth and preparation of crystals of romidepsin
#108PAR-1 based therapeutic conjugates and uses thereof
#109Neurogenic brain-derived neurotrophic factor peptides
#110Covalent granzyme B inhibitors
#111NOVEL ULTRASHORT HYDROPHOBIC PEPTIDES THAT SELF-ASSEMBLE INTO NANOFIBROUS HYDROGELS AND THEIR USES
#112Self-assembling peptides, peptidomimetics and peptidic conjugates as building blocks for biofabrication and printing
#113Synthetic peptide amides
#114Biologically cleavable tetrapeptide linking agents
#115Homo- and heterodimeric SMAC mimetic compounds as apoptosis inducers
#116Method for preventing or treating heart diseases by using a composition containing an isolated peptide
#117METHOD OF PRODUCING FR901228
#118SELECTIVE INHIBITORS OF PROTEINASE 3
#119Connective tissue stimulating peptides
#120SITE-SPECIFIC CHEMOENZYMATIC PROTEIN MODIFICATIONS
#121PEPTIDE CONSTRUCTS AND WELL-DEFINED AGGREGATES THEREOF
#122Aminostatin derivatives for the treatment of arthrosis
#123Composition comprising peptide derived from adiponectin
#124Dipeptidyl peptidase-IV (DPPIV), inhibitory peptide compound, composition containing the same, and production method for the same
#125Bidentate-binding modulators of LRRK2 and JNK kinases
#126Proprotein convertase subtilisin kexin type 9 (PCSK9) allosteric binding ligands to modulate serum low density lipoprotein (LDL) levels
#127LLP2A-bisphosphonate conjugates for osteoporosis treatment
#128Pre-treatment agent and pre-treatment method for antithrombin III to be subjected to limulus test
#129Romidepsin solid forms and uses thereof
#130Compositions containing, methods involving, and uses of non-natural amino acid linked dolastatin derivatives
#131Tunable control of protein degradation in synthetic and endogenous bacterial systems
#132Methods for the treatment of mitochondrial diseases associated with a mutation in or gene resulting in a disruption of mitochondrial oxidative phosphorylation
#133Method for preventing or treating heart diseases by using a composition containing an isolated peptide
#134Amphiphilic linear peptide/peptoid and hydrogel comprising the same
#135Mucin hypersecretion inhibitors and methods of use
#136Treatment of brain injury with a neurotrophic peptide
#137Peptides having NF-κB inhibitory activity, or composition comprising same
#138Method of producing FR901228
#139Romidepsin solid forms and uses thereof
#140INHIBITION OF GLIADIN PEPTIDES
#141Synthetic peptide amides
#142Fill-finish process for peptide solutions
#143Uses of kappa opioid synthetic peptide amides
#144Homo- and heterodimeric SMAC mimetic compounds as apoptosis inducers
#145Site-specific chemoenzymatic protein modifications
#146Cyclin based inhibitors of CDK2 and CDK4
#147Organic compounds and their uses
#148HCV NS3 protease inhibitors
#149Porcine circovirus type-2 (PCV2) subunit vaccine
#150COMPOSITION FOR IMPROVING BRAIN FUNCTION AND METHOD FOR IMPROVING BRAIN FUNCTION
#151ROMIDEPSIN SOLID FORMS AND USES THEREOF
#152Self-assembling peptides incorporating modifications and methods of use thereof
#153IPNV-ISAV bivalent vaccine using a virus-like particle-based platform and methods of using the same
#154NOVEL ANTIBACTERIAL AND FUNGICIDAL PEPTIDE IN WHICH LYSINE AND TRYPTOPHAN RESIDUES ARE REPEATED, AND USE THEREOF
#155PEPTIDOMIMETIC PROTEASE INHIBITORS
#156Method of producing peptide
#157Romidepsin solid forms and uses thereof
#158METHODS FOR REDUCING CD36 EXPRESSION
#159Methods for reducing CD36 expression
#160Phosphatidylinositol-3-kinase inhibitor and pharmaceutical composition
#161Peptide Conjugates and Fluorescence Detection Methods for Intracellular Caspase Assay
#162Template-fixed peptidomimetics
#163Amphiphilic linear peptidepeptoid and hydrogel comprising the same
#164N-carboxyalkylauristatins and use thereof
#165LLP2A-bisphosphonate conjugates for osteoporosis treatment
#166Hepatocyte growth factor mimics as therapeutic agents
#167NOVEL DIPEPTIDYL PEPTIDASE IV (DP-IV) COMPOUNDS
#168Neuroprotective and neurorestorative methods and compositions
#169Neurogenic brain-derived neurotrophic factor peptides
#170Mucin hypersecretion inhibitors and methods of use
#171Peptides and methods using same for diagnosis and treatment of amyloid-associated disease
#172Aminostatin derivatives for the treatment of arthrosis
#173HCV NS3 PROTEASE INHIBITORS
#174Neurotrophic peptides
#175ISOLATION OF MESENCHYMAL STEM CELLS
#176Cyclized peptidomimetic small molecule inhibitors of the WDR5 and MLL1 interaction
#177Polypeptides for the treatment or prevention of cancer and uses thereof
#178Lipid peptide and hydrogel
#179Neurotrophic peptides
#180PEPTIDES FOR THE REGULATION OF NEUROTRANSMITTER SEQUESTRATION AND RELEASE
#181Peptides that inhibit angiotensin converting enzyme and peptides with antioxidant activity purified from ovotransferrin and methods of producing and using the same
#182Cosmetic composition containing oligopeptides
#183Cardiovascular therapeutics
#184Peptidomimetic sulfamide compounds and antiviral uses thereof
#185C-Met receptor regulation by angiotensin IV (AT4) receptor ligands
#186Amphiphilic linear peptide/peptoid and hydrogel comprising the same
#187Peptidomimetic sulfamide compounds and antiviral uses thereof
#188COMPOSITIONS AND METHODS FOR INHIBITING MMP-9-MEDIATED CELL MIGRATION
#189Synthetic peptide amides for pain
#190Optimal hydolysis conditions of soy protein to produce peptides with lipolysis-stimulating activity and their sequencing and use thereof
#191MEANS FOR PREVENTING AND TREATING CELLULAR DEATH AND THEIR BIOLOGICAL APPLICATIONS
#192OPTIMIZED METHOD FOR OBTAINING ACE ACTIVITY INHIBITORY PEPTIDES FROM WHEY, ACE INHIBITORY PEPTIDES AND FOOD COMPRISING THEM
#193Peptidomimetic protease inhibitors
#194Process for preparing peptide products for promoting cholecystokinin secretion and use of the peptide products
#195Fish cancer model
#196REGULATION OF AUTOPHAGY PATHWAY PHOSPHORYLATION AND USES THEREOF
#197Native chemical ligation at serine and threonine sites
#198Organic compounds and their uses
#199Method of producing FR901228
#200Method of producing FR901228
#201Insulin analogues
#202ROMIDEPSIN SOLID FORMS AND USES THEREOF
#203Oligopeptides And Their Use In Cosmetics
#204Antibiotic compounds
#205Connective tissue stimulating peptides
#206Peptide ligands for G-protein coupled receptors
#207Proteasome-activating lightening peptidic hydrolyzates and compositions containing them
#208Peptidic hydrolyzate proteasome activators and compositions containing same
#209Composition for improving brain function and method for improving brain function
#210Peptidomimetic protease inhibitors
#211ROMIDEPSIN SOLID FORMS AND USES THEREOF
#212Neuroprotective and neurorestorative method and compositions
#213Proteasome-activating anti-aging peptides and compositions containing same
#214Peptides useful as dual caspase-2/-6 inhibitors and their biological applications
#215Self-assembling peptides incorporating modifications and methods of use thereof
#216G-TYPE PEPTIDES AND OTHER AGENTS TO AMELIORATE ATHEROSCLEROSIS AND OTHER PATHOLOGIES
#217Synthetic protease substrates, assay methods using such substrates and kits for practicing the assay
#218Methods and materials for generating T cells
#219Cosmetic or pharmaceutical peptides containing uncoded amino acids and their use in the treatment and/or care of the skin, mucous membranes, or scalp
#220APO-LIPOPROTEIN PROPEPTIDE
#221Inhibition of gliadin peptides
#222FUSION PROTEINS COMPRISING DP-178 AND OTHER VIRAL FUSION INHIBITOR PEPTIDES USEFUL FOR TREATING AIDS
#223Oligomeric biosurfactants in dermatocosmetic compositions
#224Uses of kappa opioid synthetic peptide amides
#225Peptide having anti-diabetic activity and use thereof
#226ORGANIC COMPOUNDS AND THEIR USES
#227Peptides for activation and inhibition of δPKC
#228Depsipeptides and their therapeutic use
#229Gene regulator
#230Method of treating an ischemia-reperfusion injury-related disorder by administering GPCR ligands
#231Antineoplastic peptides
#232Peptide conjugates and fluorescence detection methods for intracellular caspase assay
#233Skin aging-inhibiting peptide
#234METABOLITE DERIVATIVES OF THE HDAC INHIBITOR FK228
#235PROTEIN VARIANTS HAVING MODIFIED IMMUNOGENICITY
#236Stabilized liquid enzyme compositions
#237FLUOROGENIC PEPTIDES AND THEIR METHOD OF PRODUCTION
#238Organic compounds and their uses
#239Substrate for assaying β-glucan and/or endotoxin and assay method
#240Methods for reducing CD36 expression
#241Treatment of burns
#242METHODS AND COMPOSITIONS FOR INHIBITION OF MEMBRANE FUSION-ASSOCIATED EVENTS, INCLUDING HIV TRANSMISSION
#243Lipid peptide and hydrogel
#244Peptide production and purification process
#245PEPTIDE CONJUGATES AND FLUORESCENCE DETECTION METHODS FOR INTRACELLULAR CASPASE ASSAY
#246Derivatised proline containing peptide compounds as protease inhibitors
#247PEPTIDES AND PEPTIDE MIMETICS TO INHIBIT THE ONSET AND/OR PROGRESSION OF FIBROTIC AND/OR PRE-FIBROTIC PATHOLOGIES
#248PEPTIDES AND PEPTIDE MIMETICS TO TREAT CANCER
#249Mucin hypersecretion inhibitors and methods of use
#250Thrombin substrate and assay for determining the level of bioactive thrombin in a sample
#251Transfection complexes
#252Smart Pro-Drugs of Serine Protease Inhibitors
#253Polymeric biosurfactants
#254Peptidomimetic protease inhibitors
#255Oligopeptides and their use in cosmetics
#256Endothelium mimicking nanomatrix
#257MEANS FOR PREVENTING AND TREATING CELLULAR DEATH AND THEIR BIOLOGICAL APPLICATIONS
#258Peptides and methods using same for diagnosis and treatment of amyloid-associated disease
#259Template-fixed peptidomimetics
#260Peptides for the regulation of neurotransmitter sequestration and release
#261REGULATION OF APG8 PHOSPHORYLATION AND USES THEREOF
#262Regulation of autophagy pathway phosphorylation and uses thereof
#263TARGETED PHOTODYNAMIC THERAPY AGENT
#264Bioluminescent detection of cyanohydroxy benzothiazole compounds
#265Peptides Inhibiting Angiotensin-Converting Enzyme
#266Depsipeptides and their therapeutic use
#267Bioactive peptides identified in enzymatic hydrolyzates of milk caseins and method of obtaining same
#268Peptides directed for diagnosis and treatment of amyloid-associated diseases
#269Peptide turn mimetics
#270Mucin hypersecretion inhibitors and methods of use
#271Effective quantitation of complex peptide mixtures in tissue samples and improved therapeutic methods
#272METHOD OF PRODUCING FR901228
#273Methods for reducing CD36 expression
#274METHOD OF PRODUCING FR901228
#275Selective substrates for matrix metalloproteinases
#276Process for preparing peptide products for promoting cholecystokinin secretion and use of the peptide products
#277BIOLUMINESCENT CONSTRUCT
#278Methods and uses for protein breakdown products
#279PAR-2 agonist
#280Peptides that increase collagen or hyaluronic acid production
#281PREPARATION OF ROMIDEPSIN
#282Alpha-fetoprotein peptides
#283Peptides for activation and inhibition of δPKC
#284Specific inhibitors of NFAT activation by calcineurin and their use in treating immune-related diseases
#285Preparation of romidepsin
#286Peptide inhibiting angiotensin converting enzyme
#287Method of producing FR901228
#288Self-assembly and mineralization of peptide-amphiphile nanofibers
#289PROTEIN HYDROLYSATE WITH ANTIDIABETIC EFFECT
#290PEPTIDES FOR USE IN CULTURE MEDIA
#291Enzyme inhibition
#292Synthetic peptide amides
#293Protein hydrolysate enriched in peptides inhibiting DPP-IV and their use
#294Method for reducing central nervous system tissue or cell damage in a subject due to stroke
#295Method of producing peptide
#296METHODS AND COMPOSITIONS FOR TREATING CONDITIONS
#297Transfection complexes
#298ELASTIN PRODUCTION-ENHANCING AGENTS
#299Peptides which bind to G protein-coupled receptors
#300Peptides Useful As Dual Caspase-2/-6 Inhibitors And Their Biological Applications